CGEM Stock Performance and Key Statistics

CGEM has a current P/E ratio of -2.79

The CGEM stock has a trailing twelve month price-to sales (P/S) ratio of N/A while its price-to-book (P/B) value is 1.34.

CGEM's price-to-free-cashflow (P/FCF) ratio is -3.48, an indicator that is currently being trending upward.

Based on CGEM's recent bid, its distance from 20 days simple moving average is -7.11%. It is 10.95% apart from 50 days simple moving average, and it is 27.7% apart from 200 days simple moving average.

The 52-week high for CGEM is $13.33 which is -22.43% away from the current price level whereas the distance of that from the 52-week low of $5.68 stands at 82.04%.

The performance of CGEM stock was not encouraging with most of its significant price indicators in red. Cullinan Therapeutics, Inc.(NASDAQ: CGEM) shares have moved upward +6.82% or $0.66 in the latest trading session and have lost -15.11% year-to-date (YTD). The stock has lost nearly -12.37% over the past year. After moving 64.65% over the trailing 3-month period, the stock is 36.41% higher in the 6-month period. Looking at its performance over the shorter term, it'slost -13.26% a week and 22.37% a month.

The current 14-day RSI for CGEM stock is 50.56. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.

ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Cullinan Therapeutics, Inc. (CGEM) has a 14-day ATR of 0.93.

After closing at $9.68 with 59.08M of its shares outstanding, the current enterprise value of CGEM is roughly 718.67M.

Cullinan Therapeutics, Inc. (NASDAQ: CGEM) is down -12.37% when it comes to the percentage price change over the past 52-weeks. The percentage price change came less than that of broader S&P 500 index that came at a fall of 12.87%. CGEM stock price is also down -15.11% on its value in year-to-date trading.

The number outstanding shares of CGEM is 59.08M, and of these 61.03% shares are freely available for trading. On average, CGEM stock has traded 1.33M shares per day for the past 10 days. A total of 1.4M shares changed hands during the last trading session with the average session volume of 1.27M shares.